• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dramatic resolution of choroidal neovascular abnormalities after single aflibercept injection following years of ranibizumab use.

作者信息

Chaikitmongkol Voraporn, Bressler Neil M

机构信息

Retina Division, Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

出版信息

JAMA Ophthalmol. 2013 Feb;131(2):260-2. doi: 10.1001/jamaophthalmol.2013.1733.

DOI:10.1001/jamaophthalmol.2013.1733
PMID:23411901
Abstract
摘要

相似文献

1
Dramatic resolution of choroidal neovascular abnormalities after single aflibercept injection following years of ranibizumab use.在使用雷珠单抗数年之后，单次注射阿柏西普后脉络膜新生血管异常显著消退。
JAMA Ophthalmol. 2013 Feb;131(2):260-2. doi: 10.1001/jamaophthalmol.2013.1733.
2
Myopic choroidal neovascularization.近视性脉络膜新生血管形成
Ophthalmology. 2011 Dec;118(12):2521-3. doi: 10.1016/j.ophtha.2011.07.029.
3
Quantitative OCT subanalysis of eyes with choroidal neovascularization switched from multiple injections of bevacizumab or ranibizumab to intravitreal aflibercept.对从多次注射贝伐单抗或雷珠单抗转换为玻璃体内注射阿柏西普治疗的脉络膜新生血管眼进行光学相干断层扫描定量亚分析。
Ophthalmic Surg Lasers Imaging Retina. 2015 Feb;46(2):195-200. doi: 10.3928/23258160-20150213-18.
4
Efficacy of intravitreal injection of aflibercept in neovascular age-related macular degeneration with or without choroidal vascular hyperpermeability.玻璃体内注射阿柏西普治疗伴或不伴脉络膜血管高通透性的新生血管性年龄相关性黄斑变性的疗效
Invest Ophthalmol Vis Sci. 2014 Nov 13;55(12):7874-80. doi: 10.1167/iovs.14-14610.
5
Intravitreal bevacizumab in myopic neovascular membranes: 24-month results.玻璃体内注射贝伐单抗治疗近视性新生血管膜：24个月的结果。
Ophthalmology. 2013 Jul;120(7):1510-1.e1. doi: 10.1016/j.ophtha.2013.03.006.
6
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.玻璃体内注射阿柏西普治疗视网膜中央静脉阻塞所致黄斑水肿：COPERNICUS 研究 3 期的 1 年结果。
Am J Ophthalmol. 2013 Mar;155(3):429-437.e7. doi: 10.1016/j.ajo.2012.09.026. Epub 2012 Dec 4.
7
Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.抗 VEGF 治疗前后年龄相关性黄斑变性继发典型脉络膜新生血管的荧光素眼底血管造影和频域光相干断层扫描成像。
Retina. 2012 Jun;32(6):1069-76. doi: 10.1097/IAE.0b013e318240a529.
8
Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.玻璃体内雷珠单抗治疗炎症性脉络膜新生血管。
Retina. 2011 May;31(5):871-9. doi: 10.1097/IAE.0b013e3182003ca8.
9
Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks.阿柏西普治疗血管样条纹脉络膜新生血管的治疗与延长方案
Eye (Lond). 2016 Apr;30(4):637-9. doi: 10.1038/eye.2015.283. Epub 2016 Jan 22.
10
Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab.玻璃体内单次注射雷珠单抗后糖尿病性视乳头病变的消退
Acta Ophthalmol. 2012 Aug;90(5):e407-9. doi: 10.1111/j.1755-3768.2011.02282.x. Epub 2012 Jan 23.

引用本文的文献

1
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.阿柏西普治疗对贝伐单抗和雷珠单抗耐药的渗出性年龄相关性黄斑变性
Int J Retina Vitreous. 2021 Apr 1;7(1):26. doi: 10.1186/s40942-021-00299-4.
2
Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study.康柏西普与雷珠单抗治疗新生血管性年龄相关性黄斑变性的有效性和安全性比较。一项回顾性、病例对照、非劣效性、多中心研究。
Eye (Lond). 2018 Feb;32(2):391-399. doi: 10.1038/eye.2017.187. Epub 2017 Sep 22.
3
Polypoidal Choroidal Vasculopathy in Asians.
亚洲人的息肉样脉络膜血管病变
J Clin Med. 2015 Apr 24;4(5):782-821. doi: 10.3390/jcm4050782.
4
Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).对于先前接受雷珠单抗或贝伐单抗治疗渗出性年龄相关性黄斑变性的患者，转换为阿柏西普治疗6个月后的光学相干断层扫描和视力结果（美国眼科学会论文）
Trans Am Ophthalmol Soc. 2014 Jul;112:160-98.
5
Resolution of persistent pigment epithelial detachment secondary to polypoidal choroidal vasculopathy in response to Aflibercept.继发于息肉样脉络膜血管病变的持续性色素上皮脱离在接受阿柏西普治疗后的消退情况
Eye (Lond). 2014 Sep;28(9):1148-9. doi: 10.1038/eye.2014.105. Epub 2014 May 16.
6
Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results.玻璃体内注射阿柏西普治疗顽固性新生血管性年龄相关性黄斑变性患者的视力及解剖学转归：12个月结果
Eye (Lond). 2014 Jul;28(7):895-9. doi: 10.1038/eye.2014.101. Epub 2014 May 16.
7
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema.雷珠单抗治疗年龄相关性黄斑变性和糖尿病性黄斑水肿的长期疗效。
Clin Interv Aging. 2013;8:467-83. doi: 10.2147/CIA.S36811. Epub 2013 Apr 29.